Standard BioTools Investor Relations Material
Latest events
Q2 2024
Standard BioTools
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Standard BioTools Inc
Access all reports
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. The Company focuses on the areas of molecular biology, proteomics and peptide expression analysis. Its products include electrophoresis systems, capillary electrophoresis systems (CE), microfluidics devices and sample preparation instruments. The Company's major customers include universities and colleges; biotechnology companies; pharmaceutical industry; public health laboratories; contract research organizations; channel partners such as Life Technologies Corporation; research centers/hospitals; academic researchers and other education institutions as well as government entities.
Key slides for Standard BioTools Inc
Q2 2024
Standard BioTools Inc
Q2 2024
Standard BioTools Inc
Latest articles
Qualcomm: Quality Communication and Semiconductor Innovation
Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.
13 Sep 2024
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
Ticker symbol
LAB
Country
🇺🇸 United States